SFX by Ex Libris Inc.

Title:	Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis
Source:	Human Molecular Genetics [0964-6906] Smith, K R yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Arsov, T. "Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6." American journal of human genetics 88.5 (2011): 566-573.
description	2.	Meador, Kimford J. "Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study." Lancet neurology 12.3 (2013): 244-252.
description	3.	Staropoli, John F. "A Homozygous Mutation in KCTD7 Links Neuronal Ceroid Lipofuscinosis to the Ubiquitin-Proteasome System." American journal of human genetics 91.1 (2012): 202-208.
description	4.	Meador, K. J. J. "Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years." Neurology 78.16 (2012): 1207-1214.
description	5.	Farias, R. "A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers." Neurobiology of disease 42.3 (2011): 468-474.
description	6.	Meador, Kimford J. "Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age." Brain 134.2 (2011): 396-404.
description	7.	Al-Muhaizea, Mohammad A. "Variant late infantile neuronal ceroid lipofuscinosis (CLN6 gene) in Saudi Arabia." Pediatric neurology 41.1 (2009): 74-76.
description	8.	Meador, K. J. J. "Effects of breastfeeding in children of women taking antiepileptic drugs." Neurology 75.22 (2010): 1954-1960.
description	9.	Braulke, T. "Neuronal ceroid lipofuscinoses." Biochimica et biophysica acta 1793.4 (2009): 697-709.
description	10.	Cendes, F. "Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: An MRI volumetric study." Neurology 43.6 (1993): 1083-1087.
description	11.	Lleo, A. "Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations." The American journal of geriatric psychiatry 12.2 (2004): 146-156.
description	12.	Radke, J. "Human NCL Neuropathology." Biochimica et biophysica acta (2015): 2262-6.
description	13.	Seeley, Randy J. "Expression of New Loci Associated With Obesity in Diet-Induced Obese Rats: From Genetics to Physiology." Obesity 20.2 (2011): 306-312.
description	14.	Hamed, Sherifa A A. "The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins." Journal of pharmacological sciences 98.4 (2005): 340-53.
description	15.	0, C. "ACOG Practice Bulletin No. 87: Use of psychiatric medications during pregnancy and lactation." Obstetrics and gynecology 110.5 (2007): 1179-1198.
description	16.	ACOG Committee on, Mitchell P P. "ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy." Obstetrics and gynecology 106.1 (2007): 1489-98.
description	17.	Hernndez-Daz, S. "Comparative safety of antiepileptic drugs during pregnancy." Neurology 78.21 (2012): 1692-1699.
description	18.	Borthen, I. "Pregnancy complications in patients with epilepsy." Current opinion in obstetrics & gynecology 24.2 (2012): 78-83.
description	19.	Werler, Lewis B. "Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects." Annals of epidemiology 21.11 (2011): 842-850.
description	20.	Banach, R. "Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies." Drug Safety; An International Journal of Medical Toxicology and Drug Experience 33.1 (2010): 73-79.